Octant Bio

formerly Octant

Mapping a New Universe of Medicine

Los Angeles, United States · Founded 2017 · $290.2M raised

Employees
51–200
Founded
2017
Business Model
B2B
Website
octant.bio
Total Funding
$290.2M
Last Round
$175.0M Series COct 2025
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 8 investors for this company. The full record is or through the API.

About

Octant merges next-generation biology, chemistry, and computation to engineer precision small molecule therapeutics targeting complex cellular mechanisms that cause disease, with a focus on protein misfolding correctors. The platform enables high-throughput design, build, test, learn cycles. Pipeline includes programs for RHO-adRP (Phase 1), Fabry disease, neurodegeneration, oncology, metabolism, and immunology.

Summary

Octant Bio is a Healthcare company based in Los Angeles, United States, founded in 2017. It has raised $290.2M in total across 5 rounds, most recently a $175.0M Series C round in Oct 2025. Investors include Andreessen Horowitz, Catalio Capital Management and Bristol Myers Squibb.

Tech & App Stack

13 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries COct 2025
$175.0M

Sign up to see all 5 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Octant Bio on Indexed.vc
<a href="https://indexed.vc/companies/octant-bio"><img src="https://indexed.vc/api/badge/company/octant-bio" alt="Octant Bio on Indexed.vc" width="260" height="76" /></a>